Minh Hoang Merchant is the general counsel at Kyverna Therapeutics Inc. (Nasdaq: KYTX), a pioneering CAR T-cell company developing therapies for autoimmune disease patients by harnessing the power of T cells to achieve a potentially sustained treatment-free remission by resetting the immune system. Prior to joining Kyverna, Minh was general counsel, corporate secretary, and chief compliance officer at Aspira Women’s Health, a publicly traded diagnostics company in women’s health (Nasdaq: AWH), and held those same roles prior to Aspira, at Genome Medical Inc., a private telegenomics company. Before Genome Medical, she served as associate general counsel, global director of litigation and human resources at Myriad Genetics, where she provided legal and strategic guidance on all matters of healthcare regulations, compliance, privacy, commercial relationships, federal and state regulations and clinical trials.

Minh began her corporate career at McKesson Corporation, a Fortune 5 company, where she served as chief counsel after about one decade in private legal practice. Minh graduated from UCLA School of Law, where she was the Joseph Drown Fellow. Minh has served as president of the Vietnamese American Bar Association of Northern California and was the inaugural co-chair of the National Conference of Vietnamese American Attorneys in 2008. 

Minh is a seasoned executive with deep healthcare experience, which includes companies spanning the market cap spectrum. From her contributions at a Fortune 5 public healthcare company, where she provided steady guidance on complex issues, to her strategic counsel at a nimble pre-IPO start up where she oversaw several transactions and financings just prior to its US$375 million merger with a public company, Minh has provided legal counsel and regulatory oversight on all aspects of corporate matters.